These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4637344)

  • 1. [Effect of benziodaron on purine metabolism in gout patients and healthy subjects].
    Müller MM; Bresnik W
    Klin Wochenschr; 1972 Nov; 50(21):1015-6. PubMed ID: 4637344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical biochemistry of gout].
    Greiling H
    Dtsch Med J; 1969 May; 20(10):336-41. PubMed ID: 5396909
    [No Abstract]   [Full Text] [Related]  

  • 3. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
    Thier SO; Wessler S; Avioli LV
    Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of a uricosuric drug on connective tissue metabolism.
    Greiling H; Kaneko M
    Adv Exp Med Biol; 1974; 41():693-8. PubMed ID: 4832597
    [No Abstract]   [Full Text] [Related]  

  • 5. Purine base incorporation into erythrocyte nucleotides and erythrocyte phosphoribosyltransferase activity in primary gout.
    Sperling O; Ophir R; de Vries A
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):147-51. PubMed ID: 5552535
    [No Abstract]   [Full Text] [Related]  

  • 6. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ; Herrick N
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemiluminescent assays in the study of purine metabolism.
    Giacomello A; Salerno C; Cardelli P; Santulli MC; Rossi A; Strom R
    Adv Exp Med Biol; 1989; 253A():411-5. PubMed ID: 2624221
    [No Abstract]   [Full Text] [Related]  

  • 8. Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity.
    Becker MA; Meyer LJ; Seegmiller JE
    Am J Med; 1973 Aug; 55(2):232-42. PubMed ID: 4722859
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA; Meyer LJ; Kostel PJ; Seegmiller JE
    Adv Exp Med Biol; 1973; 41():307-15. PubMed ID: 4364688
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycine-C-14 incorporation into nucleic acid purine by leucocytes obtained from normal and gouty subjects.
    Diamond HS; Friedland M; Halberstam D; Kaplan D
    Ann Rheum Dis; 1969 May; 28(3):275-80. PubMed ID: 5772523
    [No Abstract]   [Full Text] [Related]  

  • 11. Purine metabolism in female patients with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil A
    Adv Exp Med Biol; 1994; 370():69-72. PubMed ID: 7660998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
    Blétry O; Cartier P; Hamet M; Clauvel JP
    Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
    [No Abstract]   [Full Text] [Related]  

  • 13. Purine metabolism in intact erythrocytes from controls and HG-PRT deficient individuals.
    de Bruyn CH; Oei TL
    Adv Exp Med Biol; 1973; 41():223-7. PubMed ID: 4791195
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibition of xanthine oxidase activity by benzodiarone.
    Marcolongo R; Marinello E; Riario-Sforza G; Pagani R
    Clin Chim Acta; 1972 Oct; 41():91-4. PubMed ID: 4645254
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyltransferase in a gouty family with partial deficiency of the enzyme.
    Sperling O; Boer P; Eilam G; de Vries A
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):72-5. PubMed ID: 5041350
    [No Abstract]   [Full Text] [Related]  

  • 16. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O; Wyngaarden JB; Starmer CF
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine metabolism in women with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of the uricosuric action of benziodarone.
    Lemieux G; Vinay P; Gougoux A; Michaud G
    Am J Physiol; 1973 Jun; 224(6):1440-9. PubMed ID: 4197185
    [No Abstract]   [Full Text] [Related]  

  • 19. Uricosuric effect of benziodarone in man and laboratory animals: a comparative study.
    Lemieux G; Gougoux A; Vinay P; Michaud G
    Am J Physiol; 1973 Jun; 224(6):1431-9. PubMed ID: 4197184
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.